NIP
ZBH icon

Nicholas Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Nicholas Investment Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,983
Closed -$262K – 190
2020
Q3 		$262K Buy
+1,983
New +$259K 0.03% 167
2015
Q3 		– Sell
-31,942
Closed -$3.39M – 328
2015
Q2 		$3.39M Buy
31,942
+459
+1% +$50.8K 0.22% 186
2015
Q1 		$3.59M Buy
+31,483
New +$3.59M 0.22% 195
2014
Q4 		– Sell
-35,761
Closed -$3.49M – 321
2014
Q3 		$3.49M Buy
35,761
+590
+2% +$58K 0.22% 163
2014
Q2 		$3.55M Buy
+35,171
New +$3.43M 0.21% 168

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Nicholas Investment Partners's ZBH Position: Q4 2020 in Review

Nicholas Investment Partners sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 1,983 shares — an estimated $262K sold.

Nicholas Investment Partners first reported a position in ZBH in Q2 2014 and held it in 5 quarters. The position peaked at $3.59M in Q1 2015. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Nicholas Investment Partners reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Nicholas Investment Partners sold 1,983 Zimmer Biomet shares in Q4 2020, an estimated $262K.
  • Nicholas Investment Partners first reported a position in Zimmer Biomet in Q2 2014 and held it in 5 quarters.
  • Nicholas Investment Partners's Zimmer Biomet position peaked at $3.59M in Q1 2015.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Nicholas Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.